OwnershipPublicly listed · Nasdaq: BWAYSEC EDGAR company record and tickers file (Nasdaq: BWAY) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: BWAY, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026
Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.
13developments published
—US federal obligations on record
1private-offering notices since 2019
Oct 26, 2026latest development
Timeline
- Oct 26, 2026 · Company announcement
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
Company-reported - Oct 19, 2026 · Company announcement
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
Company-reported - Oct 13, 2026 · Company announcement
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
Company-reported - Sep 8, 2026 · Company announcement
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Company-reported - Aug 27, 2026 · Company announcement
BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
Company-reported - Aug 12, 2026 · Reported results
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
Company-reported - Jul 20, 2026 · Company announcement
BrainsWay Announces Strategic Investment in Radial Health, Inc.
Company-reported - Jul 16, 2026 · Company announcement
BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral
Company-reported - Jun 29, 2026 · Company announcement
BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
Company-reported - Jun 22, 2026 · Company announcement
BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives
Company-reported - Jun 9, 2026 · Company announcement
BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting
Company-reported - May 18, 2026 · Company announcement
BrainsWay Announces Minority-Stake Investment in Hopemark Health
Company-reported - May 13, 2026 · Reported results
BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
Company-reported
Profile
- Legal name
- Brainsway Ltd.
- Listing
- Nasdaq BWAY
- SEC filer
- CIK 0001505065 ↗
- SEC industry code
- Surgical & Medical Instruments & Apparatus
- Incorporated
- Israel
- Coverage
- Filings + federal awards
Mix of developments
Watch BrainsWay
Anything new from BrainsWay lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestPrivate offerings reported to the SEC (Form D)
A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.
| Filed | Form | Amount sold | Offering size | First sale | Investors | Exemption | Record |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | D | $20.0 million | $20.0 million | Sep 29, 2024 | 1 | Rule 506(b) | SEC ↗ |